CRISPR technologies for bacterial systems: Current achievements and future directions

Biotechnology Advances

Volumn 34, Issue 7, 2016, Pages 1180-1209

  Choi, Kyeong Rok ^a   Lee, Sang Yup ^a,b  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Chalmers University of Technology   (Denmark)

Author keywords

Antimicrobials; Cas9, bacteria; CRISPR Cas system; Expression regulation; Genome editing; Imaging; Typing; Vaccination of bacteria; Virome

Indexed keywords

BACTERIA; BIOTECHNOLOGY; GENE EXPRESSION; IMAGING TECHNIQUES; INDUSTRIAL MICROBIOLOGY; METABOLIC ENGINEERING; PATENTS AND INVENTIONS; VACCINES;

ANTIMICROBIALS; CRISPR/CAS SYSTEM; EXPRESSION REGULATION; TYPING; VIROME;

GENE EXPRESSION REGULATION;

ANTIMICROBIAL ACTIVITY; BACTERIUM; BIOTECHNOLOGY; CHROMOSOME; EUKARYOTE; FUTURE PROSPECT; GENE EXPRESSION; GENOME; MICROBIOLOGY; PROTEIN; VACCINATION;

BACTERIA (MICROORGANISMS); EUKARYOTA;

CRISPR ASSOCIATED PROTEIN;

BACTERIUM; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CRISPR CAS SYSTEM; GENE EDITING; GENETIC ENHANCEMENT; GENETICS; MICROBIOLOGICAL EXAMINATION; TRENDS;

BACTERIA; BACTERIOLOGICAL TECHNIQUES; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; CRISPR-ASSOCIATED PROTEINS; CRISPR-CAS SYSTEMS; GENE EDITING; GENETIC ENHANCEMENT;

EID: 84994391729     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2016.08.002     Document Type: Review

References (254)

1. Abudayyeh, O.O., Gootenberg, J.S., Konermann, S., Joung, J., Slaymaker, I.M., Cox, D.B., Shmakov, S., Makarova, K.S., Semenova, E., Minakhin, L., Severinov, K., Regev, A., Lander, E.S., Koonin, E.V., Zhang, F., C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016, 10.1126/science.aaf5573.
2. Altenbuchner, J., Editing of the Bacillus subtilis genome by the CRISPR-Cas9 system. Appl. Environ. Microbiol. 82 (2016), 5421–5427.
3. Amitai, G., Sorek, R., CRISPR-Cas adaptation: insights into the mechanism of action. Nat. Rev. Microbiol. 14 (2016), 67–76.
4. Anders, C., Niewoehner, O., Duerst, A., Jinek, M., Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature 513 (2014), 569–573.
5. Anderson, R.E., Brazelton, W.J., Baross, J.A., Using CRISPRs as a metagenomic tool to identify microbial hosts of a diffuse flow hydrothermal vent viral assemblage. FEMS Microbiol. Ecol. 77 (2011), 120–133.
6. Anton, T., Bultmann, S., Leonhardt, H., Markaki, Y., Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system. Nucleus 5 (2014), 163–172.
7. Aravind, L., Koonin, E.V., Prokaryotic homologs of the eukaryotic DNA-end-binding protein Ku, novel domains in the Ku protein and prediction of a prokaryotic double-strand break repair system. Genome Res. 11 (2001), 1365–1374.
8. Atsumi, S., Higashide, W., Liao, J.C., Direct photosynthetic recycling of carbon dioxide to isobutyraldehyde. Nat. Biotechnol. 27 (2009), 1177–1180.
9. Babu, M., Beloglazova, N., Flick, R., Graham, C., Skarina, T., Nocek, B., Gagarinova, A., Pogoutse, O., Brown, G., Binkowski, A., Phanse, S., Joachimiak, A., Koonin, E.V., Savchenko, A., Emili, A., Greenblatt, J., Edwards, A.M., Yakunin, A.F., A dual function of the CRISPR-Cas system in bacterial antivirus immunity and DNA repair. Mol. Microbiol. 79 (2011), 484–502.
10. Badrinarayanan, A., Le, T.B., Laub, M.T., Bacterial chromosome organization and segregation. Annu. Rev. Cell Dev. Biol. 31 (2015), 171–199.
11. Bailey, J.E., Toward a science of metabolic engineering. Science 252 (1991), 1668–1675.
12. Barrangou, R., Diversity of CRISPR-Cas immune systems and molecular machines. Genome Biol., 16, 2015, 247.
13. Barrangou, R., The roles of CRISPR-Cas systems in adaptive immunity and beyond. Curr. Opin. Immunol. 32 (2015), 36–41.
14. Barrangou, R., Dudley, E.G., CRISPR-based typing and next-generation tracking technologies. Annu. Rev. Food Sci. Technol. 7 (2016), 395–411.
15. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., Horvath, P., CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
16. Bassalo, M.C., Garst, A.D., Halweg-Edwards, A.L., Grau, W.C., Domaille, D.W., Mutalik, V.K., Arkin, A.P., Gill, R.T., Rapid and efficient one-step metabolic pathway integration in E. coli. ACS Synth. Biol., 2016, 10.1021/acssynbio.5b00187.
17. Bassuk, A.G., Zheng, A., Li, Y., Tsang, S.H., Mahajan, V.B., Precision medicine: genetic repair of Retinitis pigmentosa in patient-derived stem cells. Sci. Rep., 6, 2016, 19969.
18. Becker, J., Wittmann, C., Advanced biotechnology: metabolically engineered cells for the bio-based production of chemicals and fuels, materials, and health-care products. Angew. Chem. Int. Ed. Engl. 54 (2015), 3328–3350.
19. Bikard, D., Hatoum-Aslan, A., Mucida, D., Marraffini, L.A., CRISPR interference can prevent natural transformation and virulence acquisition during in vivo bacterial infection. Cell Host Microbe 12 (2012), 177–186.
20. Bikard, D., Jiang, W.Y., Samai, P., Hochschild, A., Zhang, F., Marraffini, L.A., Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system. Nucleic Acids Res. 41 (2013), 7429–7437.
21. Bikard, D., Euler, C.W., Jiang, W., Nussenzweig, P.M., Goldberg, G.W., Duportet, X., Fischetti, V.A., Marraffini, L.A., Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat. Biotechnol. 32 (2014), 1146–1150.
22. Bolotin, A., Quinquis, B., Sorokin, A., Ehrlich, S.D., Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151 (2005), 2551–2561.
23. Bowater, R., Doherty, A.J., Making ends meet: repairing breaks in bacterial DNA by non-homologous end-joining. PLoS Genet., 2, 2006, e8.
24. Broadbent, J.R., Neeno-Eckwall, E.C., Stahl, B., Tandee, K., Cai, H., Morovic, W., Horvath, P., Heidenreich, J., Perna, N.T., Barrangou, R., Steele, J.L., Analysis of the Lactobacillus casei supragenome and its influence in species evolution and lifestyle adaptation. BMC Genomics, 13, 2012, 533.
25. Brouns, S.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J., Snijders, A.P., Dickman, M.J., Makarova, K.S., Koonin, E.V., van der Oost, J., Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321 (2008), 960–964.
26. Bruder, M.R., Pyne, M.E., Moo-Young, M., Chung, D.A., Chou, C.P., Extending CRISPR-Cas9 technology from genome editing to transcriptional engineering in Clostridium. Appl. Environ. Microbiol., 2016.
27. Bryant, J.A., Sellars, L.E., Busby, S.J., Lee, D.J., Chromosome position effects on gene expression in Escherichia coli K-12. Nucleic Acids Res. 42 (2014), 11383–11392.
28. Cady, K.C., White, A.S., Hammond, J.H., Abendroth, M.D., Karthikeyan, R.S., Lalitha, P., Zegans, M.E., O'Toole, G.A., Prevalence, conservation and functional analysis of Yersinia and Escherichia CRISPR regions in clinical Pseudomonas aeruginosa isolates. Microbiology 157 (2011), 430–437.
29. Carroll, D., Genome engineering with targetable nucleases. Annu. Rev. Biochem. 83 (2014), 409–439.
30. Charpentier, E., Marraffini, L.A., Harnessing CRISPR-Cas9 immunity for genetic engineering. Curr. Opin. Microbiol. 19 (2014), 114–119.
31. Charpentier, E., inventors unspecified. 2016. Zusammensetzungen für die durch RNA gesteuerte modifikation einer ziel-DNA und für die durch RNA gesteuerte modulation der transkription. DE patent 202013012240.
32. Chavez, A., Scheiman, J., Vora, S., Pruitt, B.W., Tuttle, M., Iyer E.P.R., Lin, S., Kiani, S., Guzman, C.D., Wiegand, D.J., Ter-Ovanesyan, D., Braff, J.L., Davidsohn, N., Housden, B.E., Perrimon N., Weiss, R., Aach, J., Collins, J.J., Church, G.M., Highly efficient Cas9-mediated transcriptional programming. Nat. Methods 12 (2015), 326–328.
33. Chen, B., Gilbert, L.A., Cimini, B.A., Schnitzbauer, J., Zhang, W., Li, G.W., Park, J., Blackburn, E.H., Weissman, J.S., Qi, L.S., Huang, B., Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155 (2013), 1479–1491.
34. Cheng, A.W., Wang, H., Yang, H., Shi, L., Katz, Y., Theunissen, T.W., Rangarajan, S., Shivalila, C.S., Dadon, D.B., Jaenisch, R., Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res. 23 (2013), 1163–1171.
35. Cheng, A.W., Jillette, N., Lee, P., Plaskon, D., Fujiwara, Y., Wang, W., Taghbalout, A., Wang, H., Casilio: a versatile CRISPR-Cas9-Pumilio hybrid for gene regulation and genomic labeling. Cell Res. 26 (2016), 254–257.
36. Cho, S.W., Kim, S., Kim, J.M., Kim, J.S., Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease. Nat. Biotechnol. 31 (2013), 230–232.
37. Choi, K.R., Shin, J.H., Cho, J.S., Yang, D., Lee, S.Y., Systems metabolic engineering of Escherichia coli. EcoSal Plus, 2016, 10.1128/ecosalplus.ESP-0010-2015.
38. Choudhary, E., Thakur, P., Pareek, M., Agarwal, N., Gene silencing by CRISPR interference in mycobacteria. Nat. Commun., 6, 2015, 6267.
39. Chung, M.E., Yeh, I.H., Sung, L.Y., Wu, M.Y., Chao, Y.P., Ng, I.S., Hu, Y.C., Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9. Biotechnol. Bioeng., 2016.
40. Citorik, R.J., Mimee, M., Lu, T.K., Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat. Biotechnol. 32 (2014), 1141–1145.
41. Cleto, S., Jensen, J.V., Wendisch, V.F., Lu, T.K., Corynebacterium glutamicum metabolic engineering with CRISPR interference (CRISPRi). ACS Synth. Biol. 5 (2016), 375–385.
42. Cobb, R.E., Wang, Y., Zhao, H., High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system. ACS Synth. Biol. 4 (2015), 723–728.
43. Colon, G.E., Nguyen, T.T., Jetten, M.S., Sinskey, A.J., Stephanopoulos, G., Production of isoleucine by overexpression of ilvA in a Corynebacterium lactofermentum threonine producer. Appl. Microbiol. Biotechnol. 43 (1995), 482–488.
44. Cong, L., Ran, F.A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P.D., Wu, X., Jiang, W., Marraffini, L.A., Zhang, F., Multiplex genome engineering using CRISPR/Cas systems. Science 339 (2013), 819–823.
45. Cox, S., Super-resolution imaging in live cells. Dev. Biol. 401 (2015), 175–181.
46. Cress, B.F., Toparlak, O.D., Guleria, S., Lebovich, M., Stieglitz, J.T., Englaender, J.A., Jones, J.A., Linhardt, R.J., Koffas, M.A., CRISPathBrick: modular combinatorial assembly of type II-A CRISPR arrays for dCas9-mediated multiplex transcriptional repression in E. coli. ACS Synth. Biol. 4 (2015), 987–1000.
47. Cress, B.F., Trantas, E.A., Ververidis, F., Linhardt, R.J., Koffas, M.A., Sensitive cells: enabling tools for static and dynamic control of microbial metabolic pathways. Curr. Opin. Biotechnol. 36 (2015), 205–214.
48. Cress, B.F., Jones, J.A., Kim, D.C., Leitz, Q.D., Englaender, J.A., Collins, S.M., Linhardt, R.J., Koffas, M.A., Rapid generation of CRISPR/dCas9-regulated, orthogonally repressible hybrid T7-lac promoters for modular, tuneable control of metabolic pathway fluxes in Escherichia coli. Nucleic Acids Res. 44 (2016), 4472–4485.
49. Cui, L., Bikard, D., Consequences of Cas9 cleavage in the chromosome of Escherichia coli. Nucleic Acids Res. 44 (2016), 4243–4251.
50. Cui, Y., Li, Y., Gorge, O., Platonov, M.E., Yan, Y., Guo, Z., Pourcel, C., Dentovskaya, S.V., Balakhonov, S.V., Wang, X., Song, Y., Anisimov, A.P., Vergnaud, G., Yang, R., Insight into microevolution of Yersinia pestis by clustered regularly interspaced short palindromic repeats. PLoS One, 3, 2008, e2652.
51. Dahlman, J.E., Abudayyeh, O.O., Joung, J., Gootenberg, J.S., Zhang, F., Konermann, S., Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat. Biotechnol. 33 (2015), 1159–1161.
52. Datsenko, K.A., Wanner, B.L., One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 6640–6645.
53. Datsenko, K.A., Pougach, K., Tikhonov, A., Wanner, B.L., Severinov, K., Semenova, E., Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat. Commun., 3, 2012, 945.
54. Datta, S., Costantino, N., Court, D.L., A set of recombineering plasmids for Gram-negative bacteria. Gene 379 (2006), 109–115.
55. D'Auria, G., Jimenez-Hernandez, N., Peris-Bondia, F., Moya, A., Latorre, A., Legionella pneumophila pangenome reveals strain-specific virulence factors. BMC Genomics, 11, 2010, 181.
56. Deltcheva, E., Chylinski, K., Sharma, C.M., Gonzales, K., Chao, Y., Pirzada, Z.A., Eckert, M.R., Vogel, J., Charpentier, E., CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471 (2011), 602–607.
57. Deng, L., Garrett, R.A., Shah, S.A., Peng, X., She, Q., A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol. Microbiol. 87 (2013), 1088–1099.
58. Deng, W., Shi, X., Tjian, R., Lionnet, T., Singer, R.H., CASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 11870–11875.
59. Dickinson, D.J., Ward, J.D., Reiner, D.J., Goldstein, B., Engineering the Caenorhabditis elegans genome using Cas9-triggered homologous recombination. Nat. Methods 10 (2013), 1028–1034.
60. Didovyk, A., Borek, B., Hasty, J., Tsimring, L., Orthogonal modular gene repression in Escherichia coli using engineered CRISPR/Cas9. ACS Synth. Biol. 5 (2016), 81–88.
61. Doench, J.G., Hartenian, E., Graham, D.B., Tothova, Z., Hegde, M., Smith, I., Sullender, M., Ebert, B.L., Xavier, R.J., Root, D.E., Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation. Nat. Biotechnol. 32 (2014), 1262–1267.
62. Dominguez, A.A., Lim, W.A., Qi, L.S., Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat. Rev. Mol. Cell Biol. 17 (2016), 5–15.
63. Dong, D., Ren, K., Qiu, X., Zheng, J., Guo, M., Guan, X., Liu, H., Li, N., Zhang, B., Yang, D., Ma, C., Wang, S., Wu, D., Ma, Y., Fan, S., Wang, J., Gao, N., Huang, Z., The crystal structure of Cpf1 in complex with CRISPR RNA. Nature 532 (2016), 522–526.
64. Doudna, J.A., Jinek, M., Charpentier, E., Chylinski, K., Cate, J.H.D., Lim, W., Qi, L. 2013. Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription. US patent 20140068797.
65. Dupuis, M.E., Villion, M., Magadan, A.H., Moineau, S., CRISPR-Cas and restriction-modification systems are compatible and increase phage resistance. Nat. Commun., 4, 2013, 2087.
66. Farzadfard, F., Perli, S.D., Lu, T.K., Tunable and multifunctional eukaryotic transcription factors based on CRISPR/Cas. ACS Synth. Biol. 2 (2013), 604–613.
67. Fonfara, I., Richter, H., Bratovic, M., Le Rhun, A., Charpentier, E., The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature 532 (2016), 517–521.
68. Fu, Y., Foden, J.A., Khayter, C., Maeder, M.L., Reyon, D., Joung, J.K., Sander, J.D., High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat. Biotechnol. 31 (2013), 822–826.
69. Gao, F., Shen, X.Z., Jiang, F., Wu, Y., Han, C., DNA-guided genome editing using the Natronobacterium gregoryi Argonaute. Nat. Biotechnol., 2016, 10.1038/nbt.3547.
70. Garneau, J.E., Dupuis, M.E., Villion, M., Romero, D.A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadan, A.H., Moineau, S., The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468 (2010), 67–71.
71. Gasiunas, G., Barrangou, R., Horvath, P., Siksnys, V., Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), E2579–E2586.
72. Gilbert, L.A., Larson, M.H., Morsut, L., Liu, Z., Brar, G.A., Torres, S.E., Stern-Ginossar, N., Brandman, O., Whitehead, E.H., Doudna, J.A., Lim, W.A., Weissman, J.S., Qi, L.S., CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell 154 (2013), 442–451.
73. Goldberg, G.W., Jiang, W., Bikard, D., Marraffini, L.A., Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 514 (2014), 633–637.
74. Gomaa, A.A., Klumpe, H.E., Luo, M.L., Selle, K., Barrangou, R., Beisel, C.L., Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. MBio, 5, 2014 e00928-00913.
75. Grissa, I., Vergnaud, G., Pourcel, C., The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinforma., 8, 2007, 172.
76. Groenen, P.M., Bunschoten, A.E., van Soolingen, D., van Embden, J.D., Nature of DNA polymorphism in the direct repeat cluster of Mycobacterium tuberculosis; application for strain differentiation by a novel typing method. Mol. Microbiol. 10 (1993), 1057–1065.
77. Guilinger, J.P., Thompson, D.B., Liu, D.R., Fusion of catalytically inactive Cas9 to FokI nuclease improves the specificity of genome modification. Nat. Biotechnol. 32 (2014), 577–582.
78. Gunderson, F.F., Cianciotto, N.P., The CRISPR-associated gene cas2 of Legionella pneumophila is required for intracellular infection of amoebae. MBio, 4, 2013 e00074-00013.
79. Haft, D.H., Selengut, J., Mongodin, E.F., Nelson, K.E., A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput. Biol., 1, 2005, e60.
80. Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns, R.M., Terns, M.P., RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139 (2009), 945–956.
81. Hale, C.R., Majumdar, S., Elmore, J., Pfister, N., Compton, M., Olson, S., Resch, A.M., Glover, C.V. 3rd, Graveley, B.R., Terns, R.M., Terns, M.P., Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol. Cell 45 (2012), 292–302.
82. Hall, T.M., Structure and function of Argonaute proteins. Structure 13 (2005), 1403–1408.
83. Hargreaves, K.R., Flores, C.O., Lawley, T.D., Clokie, M.R., Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen. MBio, 5, 2014 e01045-01013.
84. Hatoum-Aslan, A., Maniv, I., Marraffini, L.A., Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 21218–21222.
85. Heidelberg, J.F., Nelson, W.C., Schoenfeld, T., Bhaya, D., Germ warfare in a microbial mat community: CRISPRs provide insights into the co-evolution of host and viral genomes. PLoS One, 4, 2009, e4169.
86. Heler, R., Samai, P., Modell, J.W., Weiner, C., Goldberg, G.W., Bikard, D., Marraffini, L.A., Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature 519 (2015), 199–202.
87. Horvath, P., Romero, D.A., Coute-Monvoisin, A.C., Richards, M., Deveau, H., Moineau, S., Boyaval, P., Fremaux, C., Barrangou, R., Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J. Bacteriol. 190 (2008), 1401–1412.
88. Hruscha, A., Krawitz, P., Rechenberg, A., Heinrich, V., Hecht, J., Haass, C., Schmid, B., Efficient CRISPR/Cas9 genome editing with low off-target effects in zebrafish. Development 140 (2013), 4982–4987.
89. Hsu, P.D., Scott, D.A., Weinstein, J.A., Ran, F.A., Konermann, S., Agarwala, V., Li, Y., Fine, E.J., Wu, X., Shalem, O., Cradick, T.J., Marraffini, L.A., Bao, G., Zhang, F., DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31 (2013), 827–832.
90. Hsu, P.D., Lander, E.S., Zhang, F., Development and applications of CRISPR-Cas9 for genome engineering. Cell 157 (2014), 1262–1278.
91. Huang, H., Zheng, G., Jiang, W., Hu, H., Lu, Y., One-step high-efficiency CRISPR/Cas9-mediated genome editing in Streptomyces. Acta Biochim. Biophys. Sin. (Shanghai) 47 (2015), 231–243.
92. Hur, J.K., Kim, K., Been, K.W., Baek, G., Ye, S., Hur, J.W., Ryu, S.-M., Lee, Y.S., Kim, J.-S., Targeted mutagenesis in mice by electroporation of Cpf1 ribonucleoproteins. Nat. Biotechnol., 2016, 10.1038/nbt.3596.
93. Hutvagner, G., Simard, M.J., Argonaute proteins: key players in RNA silencing. Nat. Rev. Mol. Cell Biol. 9 (2008), 22–32.
94. Hwang, W.Y., Fu, Y., Reyon, D., Maeder, M.L., Tsai, S.Q., Sander, J.D., Peterson, R.T., Yeh, J.R., Joung, J.K., Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat. Biotechnol. 31 (2013), 227–229.
95. Isaacs, F.J., Carr, P.A., Wang, H.H., Lajoie, M.J., Sterling, B., Kraal, L., Tolonen, A.C., Gianoulis, T.A., Goodman, D.B., Reppas, N.B., Emig, C.J., Bang, D., Hwang, S.J., Jewett, M.C., Jacobson, J.M., Church, G.M., Precise manipulation of chromosomes in vivo enables genome-wide codon replacement. Science 333 (2011), 348–353.
96. Ishino, Y., Shinagawa, H., Makino, K., Amemura, M., Nakata, A., Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J. Bacteriol. 169 (1987), 5429–5433.
97. Jackson, R.N., Golden, S.M., van Erp, P.B., Carter, J., Westra, E.R., Brouns, S.J., van der Oost, J., Terwilliger, T.C., Read, R.J., Wiedenheft, B., Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 345 (2014), 1473–1479.
98. Jakutyte-Giraitiene, L., Gasiunas, G., Design of a CRISPR-Cas system to increase resistance of Bacillus subtilis to bacteriophage SPP1. J. Ind. Microbiol. Biotechnol., 2016, 10.1007/s10295-016-1784-0.
99. Jansen, R., Embden, J.D., Gaastra, W., Schouls, L.M., Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43 (2002), 1565–1575.
100. Ji, W., Lee, D., Wong, E., Dadlani, P., Dinh, D., Huang, V., Kearns, K., Teng, S., Chen, S., Haliburton, J., Heimberg, G., Heineike, B., Ramasubramanian, A., Stevens, T., Helmke, K.J., Zepeda, V., Qi, L.S., Lim, W.A., Specific gene repression by CRISPRi system transferred through bacterial conjugation. ACS Synth. Biol. 3 (2014), 929–931.
101. Jiang, W., Bikard, D., Cox, D., Zhang, F., Marraffini, L.A., RNA-guided editing of bacterial genomes using CRISPR-Cas systems. Nat. Biotechnol. 31 (2013), 233–239.
102. Jiang, Y., Chen, B., Duan, C., Sun, B., Yang, J., Yang, S., Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system. Appl. Environ. Microbiol. 81 (2015), 2506–2514.
103. Jiang, F., Zhou, K., Ma, L., Gressel, S., Doudna, J.A., A Cas9-guide RNA complex preorganized for target DNA recognition. Science 348 (2015), 1477–1481.
104. Jiang, F., Taylor, D.W., Chen, J.S., Kornfeld, J.E., Zhou, K., Thompson, A.J., Nogales, E., Doudna, J.A., Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage. Science 351 (2016), 867–871.
105. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J.A., Charpentier, E., A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337 (2012), 816–821.
106. Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., Doudna, J., RNA-programmed genome editing in human cells. Elife, 2, 2013, e00471.
107. Jinek, M., Cate, J.H.D., Lim, W., Qi, L., Chylinski, K., Charpentier, E., Doudna, J. 2016. Methods and compositions for RNA-directed target DNA modification. UK patent 2518764.
108. Jore, M.M., Lundgren, M., van Duijn, E., Bultema, J.B., Westra, E.R., Waghmare, S.P., Wiedenheft, B., Pul, U., Wurm, R., Wagner, R., Beijer, M.R., Barendregt, A., Zhou, K., Snijders, A.P., Dickman, M.J., Doudna, J.A., Boekema, E.J., Heck, A.J., van der Oost, J., Brouns, S.J., Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat. Struct. Mol. Biol. 18 (2011), 529–536.
109. Kaiser, J., First proposed human test of CRISPR passes initial safety review. Science, 2016, 10.1126/science.aaf5796.
110. Kanchiswamy, C.N., Malnoy, M., Velasco, R., Kim, J.S., Viola, R., Non-GMO genetically edited crop plants. Trends Biotechnol. 33 (2015), 489–491.
111. Kiani, S., Chavez, A., Tuttle, M., Hall, R.N., Chari, R., Ter-Ovanesyan, D., Qian, J., Pruitt, B.W., Beal, J., Vora, S., Buchthal, J., Kowal, E.J., Ebrahimkhani, M.R., Collins, J.J., Weiss, R., Church, G., Cas9 gRNA engineering for genome editing, activation and repression. Nat. Methods 12 (2015), 1051–1054.
112. Kim, S., Kim, D., Cho, S.W., Kim, J., Kim, J.S., Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24 (2014), 1012–1019.
113. Kim, D., Bae, S., Park, J., Kim, E., Kim, S., Yu, H.R., Hwang, J., Kim, J.I., Kim, J.S., Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat. Methods 12 (2015), 237–243.
114. Kinnevey, P.M., Shore, A.C., Brennan, G.I., Sullivan, D.J., Ehricht, R., Monecke, S., Slickers, P., Coleman, D.C., Emergence of sequence type 779 methicillin-resistant Staphylococcus aureus harboring a novel pseudo staphylococcal cassette chromosome mec (SCCmec)-SCC-SCCCRISPR composite element in Irish hospitals. Antimicrob. Agents Chemother. 57 (2013), 524–531.
115. Komor, A.C., Kim, Y.B., Packer, M.S., Zuris, J.A., Liu, D.R., Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533 (2016), 420–424.
116. Konermann, S., Brigham, M.D., Trevino, A.E., Joung, J., Abudayyeh, O.O., Barcena, C., Hsu, P.D., Habib, N., Gootenberg, J.S., Nishimasu, H., Nureki, O., Zhang, F., Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex. Nature 517 (2015), 583–588.
117. Kupecz, A., Who owns CRISPR-Cas9 in Europe?. Nat. Biotechnol. 32 (2014), 1194–1196.
118. Kuscu, C., Arslan, S., Singh, R., Thorpe, J., Adli, M., Genome-wide analysis reveals characteristics of off-target sites bound by the Cas9 endonuclease. Nat. Biotechnol. 32 (2014), 677–683.
119. Lakadamyali, M., Cosma, M.P., Advanced microscopy methods for visualizing chromatin structure. FEBS Lett. 589 (2015), 3023–3030.
120. Ledford, H., Bitter fight over CRISPR patent heats up. Nature, 529, 2016, 265.
121. Lee, S.J., Song, H., Lee, S.Y., Genome-based metabolic engineering of Mannheimia succiniciproducens for succinic acid production. Appl. Environ. Microbiol. 72 (2006), 1939–1948.
122. Lee, J.S., Kwak, S.J., Kim, J., Kim, A.K., Noh, H.M., Kim, J.S., Yu, K., RNA-guided genome editing in Drosophila with the purified Cas9 protein. G3 (Bethesda), 4, 2014, 1291–1295.
123. Li, R., Townsend, C.A., Rational strain improvement for enhanced clavulanic acid production by genetic engineering of the glycolytic pathway in Streptomyces clavuligerus. Metab. Eng. 8 (2006), 240–252.
124. Li, W., Teng, F., Li, T., Zhou, Q., Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat. Biotechnol. 31 (2013), 684–686.
125. Li, M., Wang, R., Zhao, D., Xiang, H., Adaptation of the Haloarcula hispanica CRISPR-Cas system to a purified virus strictly requires a priming process. Nucleic Acids Res. 42 (2014), 2483–2492.
126. Li, Y., Lin, Z., Huang, C., Zhang, Y., Wang, Z., Tang, Y.J., Chen, T., Zhao, X., Metabolic engineering of Escherichia coli using CRISPR-Cas9 meditated genome editing. Metab. Eng. 31 (2015), 13–21.
127. Li, Q., Chen, J., Minton, N.P., Zhang, Y., Wen, Z., Liu, J., Yang, H., Zeng, Z., Ren, X., Yang, J., Gu, Y., Jiang, W., Jiang, Y., Yang, S., CRISPR-based genome editing and expression control systems in Clostridium acetobutylicum and Clostridium beijerinckii. Biotechnol. J., 2016, 10.1002/biot.201600053.
128. Lillestol, R.K., Redder, P., Garrett, R.A., Brugger, K., A putative viral defence mechanism in archaeal cells. Archaea 2 (2006), 59–72.
129. Lindenstrauss, A.G., Pavlovic, M., Bringmann, A., Behr, J., Ehrmann, M.A., Vogel, R.F., Comparison of genotypic and phenotypic cluster analyses of virulence determinants and possible role of CRISPR elements towards their incidence in Enterococcus faecalis and Enterococcus faecium. Syst. Appl. Microbiol. 34 (2011), 553–560.
130. Louwen, R., Horst-Kreft, D., de Boer, A.G., van der Graaf, L., de Knegt, G., Hamersma, M., Heikema, A.P., Timms, A.R., Jacobs, B.C., Wagenaar, J.A., Endtz, H.P., van der Oost, J., Wells, J.M., Nieuwenhuis, E.E., van Vliet, A.H., Willemsen, P.T., van Baarlen, P., van Belkum, A., A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barre syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 32 (2013), 207–226.
131. Luo, M.L., Mullis, A.S., Leenay, R.T., Beisel, C.L., Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression. Nucleic Acids Res. 43 (2015), 674–681.
132. Luo, M.L., Leenay, R.T., Beisel, C.L., Current and future prospects for CRISPR-based tools in bacteria. Biotechnol. Bioeng. 113 (2016), 930–943.
133. Lv, L., Ren, Y.L., Chen, J.C., Wu, Q., Chen, G.Q., Application of CRISPRi for prokaryotic metabolic engineering involving multiple genes, a case study: controllable P(3HB-co-4HB) biosynthesis. Metab. Eng. 29 (2015), 160–168.
134. Ma, H., Naseri, A., Reyes-Gutierrez, P., Wolfe, S.A., Zhang, S., Pederson, T., Multicolor CRISPR labeling of chromosomal loci in human cells. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 3002–3007.
135. Maeder, M.L., Linder, S.J., Cascio, V.M., Fu, Y., Ho, Q.H., Joung, J.K., CRISPR RNA-guided activation of endogenous human genes. Nat. Methods 10 (2013), 977–979.
136. Makarova, K.S., Aravind, L., Wolf, Y.I., Koonin, E.V., Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol. Direct, 6, 2011, 38.
137. Makarova, K.S., Haft, D.H., Barrangou, R., Brouns, S.J.J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F.J.M., Wolf, Y.I., Yakunin, A.F., van der Oost, J., Koonin, E.V., Evolution and classification of the CRISPR–Cas systems. Nat. Rev. Microbiol. 9 (2011), 467–477.
138. Makarova, K.S., Anantharaman, V., Aravind, L., Koonin, E.V., Live virus-free or die: coupling of antivirus immunity and programmed suicide or dormancy in prokaryotes. Biol. Direct, 7, 2012, 40.
139. Makarova, K.S., Wolf, Y.I., Alkhnbashi, O.S., Costa, F., Shah, S.A., Saunders, S.J., Barrangou, R., Brouns, S.J., Charpentier, E., Haft, D.H., Horvath, P., Moineau, S., Mojica, F.J., Terns, R.M., Terns, M.P., White, M.F., Yakunin, A.F., Garrett, R.A., van der Oost, J., Backofen, R., Koonin, E.V., An updated evolutionary classification of CRISPR-Cas systems. Nat. Rev. Microbiol. 13 (2015), 722–736.
140. Mali, P., Aach, J., Stranges, P.B., Esvelt, K.M., Moosburner, M., Kosuri, S., Yang, L., Church, G.M., CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering. Nat. Biotechnol. 31 (2013), 833–838.
141. Mali, P., Yang, L., Esvelt, K.M., Aach, J., Guell, M., DiCarlo, J.E., Norville, J.E., Church, G.M., RNA-guided human genome engineering via Cas9. Science 339 (2013), 823–826.
142. Marraffini, L.A., CRISPR-Cas immunity in prokaryotes. Nature 526 (2015), 55–61.
143. Marraffini, L.A., Sontheimer, E.J., CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322 (2008), 1843–1845.
144. Marraffini, L.A., Sontheimer, E.J., Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 463 (2010), 568–571.
145. Mathew, R., Chatterji, D., The evolving story of the omega subunit of bacterial RNA polymerase. Trends Microbiol. 14 (2006), 450–455.
146. Matthews, L.A., Simmons, L.A., Bacterial nonhomologous end joining requires teamwork. J. Bacteriol. 196 (2014), 3363–3365.
147. Meister, G., Argonaute proteins: functional insights and emerging roles. Nat. Rev. Genet. 14 (2013), 447–459.
148. Mermelstein, L.D., Papoutsakis, E.T., Petersen, D.J., Bennett, G.N., Metabolic engineering of Clostridium acetobutylicum ATCC 824 for increased solvent production by enhancement of acetone formation enzyme activities using a synthetic acetone operon. Biotechnol. Bioeng. 42 (1993), 1053–1060.
149. Minot, S., Sinha, R., Chen, J., Li, H., Keilbaugh, S.A., Wu, G.D., Lewis, J.D., Bushman, F.D., The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21 (2011), 1616–1625.
150. Minot, S., Bryson, A., Chehoud, C., Wu, G.D., Lewis, J.D., Bushman, F.D., Rapid evolution of the human gut virome. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 12450–12455.
151. Mojica, F.J., Diez-Villasenor, C., Soria, E., Juez, G., Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol. Microbiol. 36 (2000), 244–246.
152. Mojica, F.J., Diez-Villasenor, C., Garcia-Martinez, J., Soria, E., Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J. Mol. Evol. 60 (2005), 174–182.
153. Mojica, F.J., Diez-Villasenor, C., Garcia-Martinez, J., Almendros, C., Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 155 (2009), 733–740.
154. Mokrousov, I., Limeschenko, E., Vyazovaya, A., Narvskaya, O., Corynebacterium diphtheriae spoligotyping based on combined use of two CRISPR loci. Biotechnol. J. 2 (2007), 901–906.
155. Moreno-Mateos, M.A., Vejnar, C.E., Beaudoin, J.D., Fernandez, J.P., Mis, E.K., Khokha, M.K., Giraldez, A.J., CRISPRscan: designing highly efficient sgRNAs for CRISPR-Cas9 targeting in vivo. Nat. Methods 12 (2015), 982–988.
156. Mulepati, S., Orr, A., Bailey, S., Crystal structure of the largest subunit of a bacterial RNA-guided immune complex and its role in DNA target binding. J. Biol. Chem. 287 (2012), 22445–22449.
157. Mulepati, S., Heroux, A., Bailey, S., Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science 345 (2014), 1479–1484.
158. Nakayama, T., Fish, M.B., Fisher, M., Oomen-Hajagos, J., Thomsen, G.H., Grainger, R.M., Simple and efficient CRISPR/Cas9-mediated targeted mutagenesis in Xenopus tropicalis. Genesis 51 (2013), 835–843.
159. Nam, K.H., Haitjema, C., Liu, X., Ding, F., Wang, H., DeLisa, M.P., Ke, A., Cas5d protein processes pre-crRNA and assembles into a Cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure 20 (2012), 1574–1584.
160. Nelson, C.E., Hakim, C.H., Ousterout, D.G., Thakore, P.I., Moreb, E.A., Castellanos Rivera, R.M., Madhavan, S., Pan, X., Ran, F.A., Yan, W.X., Asokan, A., Zhang, F., Duan, D., Gersbach, C.A., In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 351 (2016), 403–407.
161. News, First-in-human CRISPR trial. Nat. Biotechnol., 34, 2016, 796.
162. Nielsen, A.A., Voigt, C.A., Multi-input CRISPR/Cas genetic circuits that interface host regulatory networks. Mol. Syst. Biol., 10, 2014, 763.
163. Nishimasu, H., Ran, F.A., Hsu, P.D., Konermann, S., Shehata, S.I., Dohmae, N., Ishitani, R., Zhang, F., Nureki, O., Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 156 (2014), 935–949.
164. Nunez, J.K., Lee, A.S., Engelman, A., Doudna, J.A., Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity. Nature 519 (2015), 193–198.
165. Oh, J.H., van Pijkeren, J.P., CRISPR-Cas9-assisted recombineering in Lactobacillus reuteri. Nucleic Acids Res., 42, 2014, e131.
166. Ohta, K., Beall, D.S., Mejia, J.P., Shanmugam, K.T., Ingram, L.O., Genetic improvement of Escherichia coli for ethanol production: chromosomal integration of Zymomonas mobilis genes encoding pyruvate decarboxylase and alcohol dehydrogenase II. Appl. Environ. Microbiol. 57 (1991), 893–900.
167. Peng, W., Feng, M., Feng, X., Liang, Y.X., She, Q., An archaeal CRISPR type III-B system exhibiting distinctive RNA targeting features and mediating dual RNA and DNA interference. Nucleic Acids Res. 43 (2015), 406–417.
168. Perez-Pinera, P., Kocak, D.D., Vockley, C.M., Adler, A.F., Kabadi, A.M., Polstein, L.R., Thakore, P.I., Glass, K.A., Ousterout, D.G., Leong, K.W., Guilak, F., Crawford, G.E., Reddy, T.E., Gersbach, C.A., RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat. Methods 10 (2013), 973–976.
169. Pines, G., Pines, A., Garst, A.D., Zeitoun, R.I., Lynch, S.A., Gill, R.T., Codon compression algorithms for saturation mutagenesis. ACS Synth. Biol. 4 (2015), 604–614.
170. Pourcel, C., Salvignol, G., Vergnaud, G., CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151 (2005), 653–663.
171. Price, A.A., Sampson, T.R., Ratner, H.K., Grakoui, A., Weiss, D.S., Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 6164–6169.
172. Pyne, M.E., Moo-Young, M., Chung, D.A., Chou, C.P., Coupling the CRISPR/Cas9 system with Lambda Red recombineering enables simplified chromosomal gene replacement in Escherichia coli. Appl. Environ. Microbiol. 81 (2015), 5103–5114.
173. Pyne, M.E., Bruder, M.R., Moo-Young, M., Chung, D.A., Chou, C.P., Harnessing heterologous and endogenous CRISPR-Cas machineries for efficient markerless genome editing in Clostridium. Sci. Rep., 6, 2016, 25666.
174. Qi, L.S., Larson, M.H., Gilbert, L.A., Doudna, J.A., Weissman, J.S., Arkin, A.P., Lim, W.A., Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell 152 (2013), 1173–1183.
175. Ran, F.A., Hsu, P.D., Lin, C.Y., Gootenberg, J.S., Konermann, S., Trevino, A.E., Scott, D.A., Inoue, A., Matoba, S., Zhang, Y., Zhang, F., Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154 (2013), 1380–1389.
176. Rath, D., Amlinger, L., Hoekzema, M., Devulapally, P.R., Lundgren, M., Efficient programmable gene silencing by Cascade. Nucleic Acids Res. 43 (2015), 237–246.
177. Rath, D., Amlinger, L., Rath, A., Lundgren, M., The CRISPR-Cas immune system: biology, mechanisms and applications. Biochimie 117 (2015), 119–128.
178. Reisch, C.R., Prather, K.L., The no-SCAR (Scarless Cas9 Assisted Recombineering) system for genome editing in Escherichia coli. Sci. Rep., 5, 2015, 15096.
179. Ren, X., Sun, J., Housden, B.E., Hu, Y., Roesel, C., Lin, S., Liu, L.P., Yang, Z., Mao, D., Sun, L., Wu, Q., Ji, J.Y., Xi, J., Mohr, S.E., Xu, J., Perrimon, N., Ni, J.Q., Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 19012–19017.
180. Ro, D.K., Paradise, E.M., Ouellet, M., Fisher, K.J., Newman, K.L., Ndungu, J.M., Ho, K.A., Eachus, R.A., Ham, T.S., Kirby, J., Chang, M.C., Withers, S.T., Shiba, Y., Sarpong, R., Keasling, J.D., Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440 (2006), 940–943.
181. Rouillon, C., Zhou, M., Zhang, J., Politis, A., Beilsten-Edmands, V., Cannone, G., Graham, S., Robinson, C.V., Spagnolo, L., White, M.F., Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol. Cell 52 (2013), 124–134.
182. Ryter, A., Chang, A., Localization of transcribing genes in the bacterial cell by means of high resolution autoradiography. J. Mol. Biol. 98 (1975), 797–810.
183. Samai, P., Pyenson, N., Jiang, W., Goldberg, G.W., Hatoum-Aslan, A., Marraffini, L.A., Co-transcriptional DNA and RNA cleavage during type III CRISPR-Cas immunity. Cell 161 (2015), 1164–1174.
184. Sampson, T.R., Saroj, S.D., Llewellyn, A.C., Tzeng, Y.L., Weiss, D.S., A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 497 (2013), 254–257.
185. Sashital, D.G., Wiedenheft, B., Doudna, J.A., Mechanism of foreign DNA selection in a bacterial adaptive immune system. Mol. Cell 46 (2012), 606–615.
186. Sebaihia, M., Wren, B.W., Mullany, P., Fairweather, N.F., Minton, N., Stabler, R., Thomson, N.R., Roberts, A.P., Cerdeno-Tarraga, A.M., Wang, H., Holden, M.T., Wright, A., Churcher, C., Quail, M.A., Baker, S., Bason, N., Brooks, K., Chillingworth, T., Cronin, A., Davis, P., Dowd, L., Fraser, A., Feltwell, T., Hance, Z., Holroyd, S., Jagels, K., Moule, S., Mungall, K., Price, C., Rabbinowitsch, E., Sharp, S., Simmonds, M., Stevens, K., Unwin, L., Whithead, S., Dupuy, B., Dougan, G., Barrell, B., Parkhill, J., The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38 (2006), 779–786.
187. Seed, K.D., Lazinski, D.W., Calderwood, S.B., Camilli, A., A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494 (2013), 489–491.
188. Selle, K., Klaenhammer, T.R., Barrangou, R., CRISPR-based screening of genomic island excision events in bacteria. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 8076–8081.
189. Shan, Q., Wang, Y., Li, J., Zhang, Y., Chen, K., Liang, Z., Zhang, K., Liu, J., Xi, J.J., Qiu, J.-L., Gao, C., Targeted genome modification of crop plants using a CRISPR-Cas system. Nat. Biotechnol. 31 (2013), 686–688.
190. Shariat, N., Timme, R.E., Pettengill, J.B., Barrangou, R., Dudley, E.G., Characterization and evolution of Salmonella CRISPR-Cas systems. Microbiology 161 (2015), 374–386.
191. Shen, B., Zhang, W., Zhang, J., Zhou, J., Wang, J., Chen, L., Wang, L., Hodgkins, A., Iyer, V., Huang, X., Skarnes, W.C., Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects. Nat. Methods 11 (2014), 399–402.
192. Shmakov, S., Abudayyeh, O.O., Makarova, K.S., Wolf, Y.I., Gootenberg, J.S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., Zhang, F., Koonin, E.V., Discovery and functional characterization of diverse class 2 CRISPR-Cas systems. Mol. Cell 60 (2015), 385–397.
193. Shuman, S., Glickman, M.S., Bacterial DNA repair by non-homologous end joining. Nat. Rev. Microbiol. 5 (2007), 852–861.
194. Siksnys, V., Gasiunas, G., Karvelis, T., Lubys, A., Zaliauskiene, L., Glemzaite, M., Smith, A. 2013. RNA-directed DNA cleavage by the Cas9-crRNA complex. WO patent 2013142578.
195. Singh, A.K., Carette, X., Potluri, L.P., Sharp, J.D., Xu, R., Prisic, S., Husson, R.N., Investigating essential gene function in Mycobacterium tuberculosis using an efficient CRISPR interference system. Nucleic Acids Res., 2016.
196. Sinkunas, T., Gasiunas, G., Waghmare, S.P., Dickman, M.J., Barrangou, R., Horvath, P., Siksnys, V., In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J. 32 (2013), 385–394.
197. Snyder, J.C., Bateson, M.M., Lavin, M., Young, M.J., Use of cellular CRISPR (clusters of regularly interspaced short palindromic repeats) spacer-based microarrays for detection of viruses in environmental samples. Appl. Environ. Microbiol. 76 (2010), 7251–7258.
198. Song, C.W., Lee, S.Y., Rapid one-step inactivation of single or multiple genes in Escherichia coli. Biotechnol. J. 8 (2013), 776–784.
199. Sonoda, E., Hochegger, H., Saberi, A., Taniguchi, Y., Takeda, S., Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair (Amst.) 5 (2006), 1021–1029.
200. Spilman, M., Cocozaki, A., Hale, C., Shao, Y., Ramia, N., Terns, R., Terns, M., Li, H., Stagg, S., Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol. Cell 52 (2013), 146–152.
201. Staals, R.H., Agari, Y., Maki-Yonekura, S., Zhu, Y., Taylor, D.W., van Duijn, E., Barendregt, A., Vlot, M., Koehorst, J.J., Sakamoto, K., Masuda, A., Dohmae, N., Schaap, P.J., Doudna, J.A., Heck, A.J., Yonekura, K., van der Oost, J., Shinkai, A., Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol. Cell 52 (2013), 135–145.
202. Standage-Beier, K., Zhang, Q., Wang, X., Targeted large-scale deletion of bacterial genomes using CRISPR-nickases. ACS Synth. Biol. 4 (2015), 1217–1225.
203. Stern, A., Keren, L., Wurtzel, O., Amitai, G., Sorek, R., Self-targeting by CRISPR: gene regulation or autoimmunity?. Trends Genet. 26 (2010), 335–340.
204. Stern, A., Mick, E., Tirosh, I., Sagy, O., Sorek, R., CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Res. 22 (2012), 1985–1994.
205. Sternberg, S.H., Redding, S., Jinek, M., Greene, E.C., Doudna, J.A., DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 507 (2014), 62–67.
206. Straathof, A.J.J., Transformation of biomass into commodity chemicals using enzymes or cells. Chem. Rev. 114 (2014), 1871–1908.
207. Sturino, J.M., Klaenhammer, T.R., Engineered bacteriophage-defence systems in bioprocessing. Nat. Rev. Microbiol. 4 (2006), 395–404.
208. Sun, H., Li, Y., Shi, X., Lin, Y., Qiu, Y., Zhang, J., Liu, Y., Jiang, M., Zhang, Z., Chen, Q., Sun, Q., Hu, Q., Association of CRISPR/Cas evolution with Vibrio parahaemolyticus virulence factors and genotypes. Foodborne Pathog. Dis. 12 (2015), 68–73.
209. Swarts, D.C., Mosterd, C., van Passel, M.W., Brouns, S.J., CRISPR interference directs strand specific spacer acquisition. PLoS One, 7, 2012, e35888.
210. Swarts, D.C., Makarova, K., Wang, Y., Nakanishi, K., Ketting, R.F., Koonin, E.V., Patel, D.J., van der Oost, J., The evolutionary journey of Argonaute proteins. Nat. Struct. Mol. Biol. 21 (2014), 743–753.
211. Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, C., Nwokeoji, A.O., Dickman, M.J., Horvath, P., Siksnys, V., Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol. Cell 56 (2014), 506–517.
212. Tanenbaum, M.E., Gilbert, L.A., Qi, L.S., Weissman, J.S., Vale, R.D., A protein-tagging system for signal amplification in gene expression and fluorescence imaging. Cell 159 (2014), 635–646.
213. Tang, T.H., Bachellerie, J.P., Rozhdestvensky, T., Bortolin, M.L., Huber, H., Drungowski, M., Elge, T., Brosius, J., Huttenhofer, A., Identification of 86 candidates for small non-messenger RNAs from the archaeon Archaeoglobus fulgidus. Proc. Natl. Acad. Sci. U. S. A. 99 (2002), 7536–7541.
214. Tang, T.H., Polacek, N., Zywicki, M., Huber, H., Brugger, K., Garrett, R., Bachellerie, J.P., Huttenhofer, A., Identification of novel non-coding RNAs as potential antisense regulators in the archaeon Sulfolobus solfataricus. Mol. Microbiol. 55 (2005), 469–481.
215. Tong, Y., Charusanti, P., Zhang, L., Weber, T., Lee, S.Y., CRISPR-Cas9 based engineering of actinomycetal genomes. ACS Synth. Biol. 4 (2015), 1020–1029.
216. Toro, E., Shapiro, L., Bacterial chromosome organization and segregation. Cold Spring Harb. Perspect. Biol., 2, 2010, a000349.
217. Toro, M., Cao, G., Ju, W., Allard, M., Barrangou, R., Zhao, S., Brown, E., Meng, J., Association of clustered regularly interspaced short palindromic repeat (CRISPR) elements with specific serotypes and virulence potential of shiga toxin-producing Escherichia coli. Appl. Environ. Microbiol. 80 (2014), 1411–1420.
218. Tsai, S.Q., Wyvekens, N., Khayter, C., Foden, J.A., Thapar, V., Reyon, D., Goodwin, M.J., Aryee, M.J., Joung, J.K., Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing. Nat. Biotechnol. 32 (2014), 569–576.
219. van der Oost, J., Westra, E.R., Jackson, R.N., Wiedenheft, B., Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat. Rev. Microbiol. 12 (2014), 479–492.
220. Vercoe, R.B., Chang, J.T., Dy, R.L., Taylor, C., Gristwood, T., Clulow, J.S., Richter, C., Przybilski, R., Pitman, A.R., Fineran, P.C., Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet., 9, 2013, e1003454.
221. Viollier, P.H., Thanbichler, M., McGrath, P.T., West, L., Meewan, M., McAdams, H.H., Shapiro, L., Rapid and sequential movement of individual chromosomal loci to specific subcellular locations during bacterial DNA replication. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 9257–9262.
222. Waltz, E., Gene-edited CRISPR mushroom escapes US regulation. Nature, 532, 2016, 293.
223. Wang, H.H., Isaacs, F.J., Carr, P.A., Sun, Z.Z., Xu, G., Forest, C.R., Church, G.M., Programming cells by multiplex genome engineering and accelerated evolution. Nature 460 (2009), 894–898.
224. Wang, T., Wei, J.J., Sabatini, D.M., Lander, E.S., Genetic screens in human cells using the CRISPR-Cas9 system. Science 343 (2014), 80–84.
225. Wang, Y., Zhang, Z.T., Seo, S.O., Choi, K., Lu, T., Jin, Y.S., Blaschek, H.P., Markerless chromosomal gene deletion in Clostridium beijerinckii using CRISPR/Cas9 system. J. Biotechnol. 200 (2015), 1–5.
226. Wang, J., Guleria, S., Koffas, M.A., Yan, Y., Microbial production of value-added nutraceuticals. Curr. Opin. Biotechnol. 37 (2016), 97–104.
227. Wang, Y., Zhang, Z.T., Seo, S.O., Lynn, P., Lu, T., Jin, Y.S., Blaschek, H.P., Bacterial genome editing with CRISPR-Cas9: deletion, integration, single nucleotide modification, and desirable “clean” mutant selection in Clostridium beijerinckii as an example. ACS Synth. Biol., 2016, 10.1021/acssynbio.6b00060.
228. Wang, Y., Zhang, Z.T., Seo, S.O., Lynn, P., Lu, T., Jin, Y.S., Blaschek, H.P., Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9. Biotechnol. Bioeng., 2016, 10.1002/bit.26020.
229. Wei, Y., Terns, R.M., Terns, M.P., Cas9 function and host genome sampling in type II-A CRISPR-Cas adaptation. Genes Dev. 29 (2015), 356–361.
230. Wendt, K.E., Ungerer, J., Cobb, R.E., Zhao, H., Pakrasi, H.B., CRISPR/Cas9 mediated targeted mutagenesis of the fast growing cyanobacterium Synechococcus elongatus UTEX 2973. Microb. Cell Fact., 15, 2016, 115.
231. Weng, X., Xiao, J., Spatial organization of transcription in bacterial cells. Trends Genet. 30 (2014), 287–297.
232. Westbrook, A.W., Moo-Young, M., Chou, C.P., Development of a CRISPR-Cas9 toolkit for comprehensive engineering of Bacillus subtilis. Appl. Environ. Microbiol., 2016, 10.1128/AEM.01159-16.
233. Westra, E.R., Nilges, B., van Erp, P.B., van der Oost, J., Dame, R.T., Brouns, S.J., Cascade-mediated binding and bending of negatively supercoiled DNA. RNA Biol. 9 (2012), 1134–1138.
234. Westra, E.R., van Erp, P.B., Kunne, T., Wong, S.P., Staals, R.H., Seegers, C.L., Bollen, S., Jore, M.M., Semenova, E., Severinov, K., de Vos, W.M., Dame, R.T., de Vries, R., Brouns, S.J., van der Oost, J., CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol. Cell 46 (2012), 595–605.
235. Westra, E.R., Buckling, A., Fineran, P.C., CRISPR-Cas systems: beyond adaptive immunity. Nat. Rev. Microbiol. 12 (2014), 317–326.
236. Wiedenheft, B., Lander, G.C., Zhou, K., Jore, M.M., Brouns, S.J., van der Oost, J., Doudna, J.A., Nogales, E., Structures of the RNA-guided surveillance complex from a bacterial immune system. Nature 477 (2011), 486–489.
237. Wolf, T., Gren, T., Thieme, E., Wibberg, D., Zemke, T., Puhler, A., Kalinowski, J., Targeted genome editing in the rare actinomycete Actinoplanes sp. SE50/110 by using the CRIPSR/Cas9 System. J. Biotechnol., 2016, 10.1016/j.jbiotec.2016.05.039.
238. Wolff, G., Hagen, C., Grunewald, K., Kaufmann, R., Towards correlative super-resolution fluorescence and electron cryo-microscopy. Biol. Cell., 2016, 10.1111/boc.201600008.
239. Wu, X., Scott, D.A., Kriz, A.J., Chiu, A.C., Hsu, P.D., Dadon, D.B., Cheng, A.W., Trevino, A.E., Konermann, S., Chen, S., Jaenisch, R., Zhang, F., Sharp, P.A., Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells. Nat. Biotechnol. 32 (2014), 670–676.
240. Xia, J., Wang, L., Zhu, J.B., Sun, C.J., Zheng, M.G., Zheng, L., Lou, Y.H., Shi, L., Expression of Shewanella frigidimarina fatty acid metabolic genes in E. coli by CRISPR/Cas9-coupled Lambda Red recombineering. Biotechnol. Lett. 38 (2016), 117–122.
241. Xu, T., Li, Y., Shi, Z., Hemme, C.L., Li, Y., Zhu, Y., Van Nostrand, J.D., He, Z., Zhou, J., Efficient genome editing in Clostridium cellulolyticum via CRISPR-Cas9 nickase. Appl. Environ. Microbiol. 81 (2015), 4423–4431.
242. Yamano, T., Nishimasu, H., Zetsche, B., Hirano, H., Slaymaker, I.M., Li, Y., Fedorova, I., Nakane, T., Makarova, K.S., Koonin, E.V., Ishitani, R., Zhang, F., Nureki, O., Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell 165 (2016), 949–962.
243. Yin, S., Jensen, M.A., Bai, J., Debroy, C., Barrangou, R., Dudley, E.G., The evolutionary divergence of Shiga toxin-producing Escherichia coli is reflected in clustered regularly interspaced short palindromic repeat (CRISPR) spacer composition. Appl. Environ. Microbiol. 79 (2013), 5710–5720.
244. Yin, H., Xue, W., Chen, S., Bogorad, R.L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P.A., Jacks, T., Anderson, D.G., Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat. Biotechnol. 32 (2014), 551–553.
245. Yosef, I., Goren, M.G., Qimron, U., Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res. 40 (2012), 5569–5576.
246. Yuan, Y.R., Pei, Y., Ma, J.B., Kuryavyi, V., Zhadina, M., Meister, G., Chen, H.Y., Dauter, Z., Tuschl, T., Patel, D.J., Crystal structure of A. aeolicus Argonaute, a site-specific DNA-guided endoribonuclease, provides insights into RISC-mediated mRNA cleavage. Mol. Cell 19 (2005), 405–419.
247. Zebec, Z., Manica, A., Zhang, J., White, M.F., Schleper, C., CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus. Nucleic Acids Res. 42 (2014), 5280–5288.
248. Zeng, H., Wen, S., Xu, W., He, Z., Zhai, G., Liu, Y., Deng, Z., Sun, Y., Highly efficient editing of the actinorhodin polyketide chain length factor gene in Streptomyces coelicolor M145 using CRISPR/Cas9-CodA(sm) combined system. Appl. Microbiol. Biotechnol. 99 (2015), 10575–10585.
249. Zetsche, B., Gootenberg, J.S., Abudayyeh, O.O., Slaymaker, I.M., Makarova, K.S., Essletzbichler, P., Volz, S.E., Joung, J., van der Oost, J., Regev, A., Koonin, E.V., Zhang, F., Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163 (2015), 759–771.
250. Zhang, F. 2014. CRISPR-Cas systems and methods for altering expression of gene products. US patent 8697359.
251. Zhang, F. 2015. CRISPR-Cas systems and methods for altering expression of gene products. EP patent 2764103.
252. Zhang, J., Rouillon, C., Kerou, M., Reeks, J., Brugger, K., Graham, S., Reimann, J., Cannone, G., Liu, H., Albers, S.V., Naismith, J.H., Spagnolo, L., White, M.F., Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol. Cell 45 (2012), 303–313.
253. Zhang, K., Duan, X., Wu, J., Multigene disruption in undomesticated Bacillus subtilis ATCC 6051a using the CRISPR/Cas9 system. Sci. Rep., 6, 2016, 27943.
254. Zuris, J.A., Thompson, D.B., Shu, Y., Guilinger, J.P., Bessen, J.L., Hu, J.H., Maeder, M.L., Joung, J.K., Chen, Z.Y., Liu, D.R., Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo. Nat. Biotechnol. 33 (2015), 73–80.